Naples, Italy

Enrico Maria Surace

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 139(Granted Patents)


Location History:

  • Milan, IT (2009 - 2012)
  • Naples, IT (2009 - 2021)
  • Rome, IT (2021)

Company Filing History:


Years Active: 2009-2021

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Enrico Maria Surace: Innovator in Retinal Disease Treatment

Introduction

Enrico Maria Surace is a prominent inventor based in Naples, Italy, known for his significant contributions to the field of retinal disease treatment. With a total of eight patents to his name, Surace has made remarkable strides in developing innovative solutions for eye disorders.

Latest Patents

Surace's latest patents include groundbreaking inventions such as "Synthetic promoters and uses thereof." This invention focuses on the treatment and prevention of retinal diseases using a specific polynucleotide promoter. The polynucleotide or its variant consists of a sequence that is crucial for the therapeutic approach. Additionally, he has developed "Artificial DNA-binding proteins and uses thereof," which relates to proteins with artificial DNA-binding domains. These proteins are particularly useful in treating eye disorders caused by gain-of-function mutations, such as autosomal dominant retinitis pigmentosa (ADRP).

Career Highlights

Throughout his career, Surace has worked with esteemed organizations, including Fondazione Telethon and the University of Pennsylvania. His work has been instrumental in advancing research and developing new therapeutic strategies for retinal diseases.

Collaborations

Surace has collaborated with notable colleagues, including Samuel Jotham Reich and Michael J. Tolentino. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion

Enrico Maria Surace stands out as a key figure in the innovation of treatments for retinal diseases. His patents reflect a commitment to improving the lives of individuals affected by eye disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…